Reaction
Monocyte Percentage Increased reporting signals
As of the last recalculation, Monocyte Percentage Increased appears in 698 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 218.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 118 | 218.7 | 220.1 |
| Dimenhydrinate | 43 | 128.2 | 128.7 |
| Methylprednisolone Sodium Succinate | 61 | 42.8 | 42.9 |
| Letrozole Tablets | 34 | 22.1 | 22.1 |
| Amantadine | 10 | 19.5 | 19.6 |
| Letrozole | 38 | 19.4 | 19.4 |
| Fingolimod Hcl | 51 | 18.9 | 18.9 |
| Oxybutynin | 15 | 15.6 | 15.6 |
| Palbociclib | 45 | 15.0 | 15.0 |
| Crizotinib | 6 | 14.2 | 14.2 |
| Ranitidine | 67 | 11.0 | 11.0 |
| Bosutinib | 3 | 10.0 | 10.0 |